VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
GE HealthCare Technologies Inc. vs Johnson & Johnson
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
GE HealthCare Technologies Inc.
GEHC · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into GE HealthCare Technologies Inc.'s moat claims, evidence, and risks.
View GEHC analysisJohnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisComparison highlights
- Moat score gap: GE HealthCare Technologies Inc. leads (63 / 100 vs 61 / 100 for Johnson & Johnson).
- Segment focus: GE HealthCare Technologies Inc. has 4 segments (45% in Imaging); Johnson & Johnson has 2 segments (64.1% in Innovative Medicine).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: GE HealthCare Technologies Inc. has 8 moat types across 4 domains; Johnson & Johnson has 5 across 3.
Primary market context
GE HealthCare Technologies Inc.
Imaging
Diagnostic imaging equipment and related service (CT, MR, molecular imaging, X-ray, women's health) and imaging IT
Global
Hospitals, imaging centers
OEM + service + software
45%
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.1%
Side-by-side metrics
Moat coverage
Shared moat types
GE HealthCare Technologies Inc. strengths
Johnson & Johnson strengths
Segment mix
GE HealthCare Technologies Inc. segments
Full profile >Imaging
Oligopoly
Advanced Visualization Solutions (AVS)
Oligopoly
Patient Care Solutions (PCS)
Oligopoly
Pharmaceutical Diagnostics (PDx)
Oligopoly
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.